Elevance Health Price to Book Ratio 2010-2024 | ELV
Historical price to book ratio values for Elevance Health (ELV) over the last 10 years. The current price to book ratio for Elevance Health as of November 22, 2024 is 2.13.
Please refer to the Stock Price Adjustment Guide for more information on our historical prices.
| Elevance Health Price/Book Ratio Historical Data | |||
|---|---|---|---|
| Date | Stock Price | Book Value per Share | Price to Book Ratio |
| 2024-11-21 | 403.60 | 2.13 | |
| 2024-09-30 | 520.00 | $189.19 | 2.75 |
| 2024-06-30 | 540.24 | $182.39 | 2.96 |
| 2024-03-31 | 515.42 | $175.06 | 2.94 |
| 2023-12-31 | 467.21 | $169.07 | 2.76 |
| 2023-09-30 | 430.08 | $164.06 | 2.62 |
| 2023-06-30 | 437.41 | $162.43 | 2.69 |
| 2023-03-31 | 451.25 | $157.98 | 2.86 |
| 2022-12-31 | 501.81 | $152.67 | 3.29 |
| 2022-09-30 | 443.27 | $150.82 | 2.94 |
| 2022-06-30 | 469.70 | $149.41 | 3.14 |
| 2022-03-31 | 476.85 | $149.42 | 3.19 |
| 2021-12-31 | 448.75 | $149.43 | 3.00 |
| 2021-09-30 | 359.89 | $147.45 | 2.44 |
| 2021-06-30 | 367.46 | $143.68 | 2.56 |
| 2021-03-31 | 344.46 | $138.48 | 2.49 |
| 2020-12-31 | 307.09 | $135.28 | 2.27 |
| 2020-09-30 | 256.12 | $135.99 | 1.88 |
| 2020-06-30 | 249.89 | $136.66 | 1.83 |
| 2020-03-31 | 215.03 | $125.76 | 1.71 |
| 2019-12-31 | 285.06 | $125.45 | 2.27 |
| 2019-09-30 | 225.98 | $123.46 | 1.83 |
| 2019-06-30 | 264.76 | $120.34 | 2.20 |
| 2019-03-31 | 268.47 | $116.56 | 2.30 |
| 2018-12-31 | 245.04 | $110.88 | 2.21 |
| 2018-09-30 | 255.70 | $112.36 | 2.28 |
| 2018-06-30 | 221.48 | $110.42 | 2.01 |
| 2018-03-31 | 203.76 | $105.71 | 1.93 |
| 2017-12-31 | 208.00 | $103.49 | 2.01 |
| 2017-09-30 | 174.98 | $100.81 | 1.74 |
| 2017-06-30 | 172.74 | $100.46 | 1.72 |
| 2017-03-31 | 151.33 | $98.43 | 1.54 |
| 2016-12-31 | 131.04 | $95.17 | 1.38 |
| 2016-09-30 | 113.71 | $93.94 | 1.21 |
| 2016-06-30 | 118.57 | $92.09 | 1.29 |
| 2016-03-31 | 124.87 | $89.59 | 1.39 |
| 2015-12-31 | 124.66 | $88.21 | 1.41 |
| 2015-09-30 | 124.57 | $89.02 | 1.40 |
| 2015-06-30 | 145.43 | $88.17 | 1.65 |
| 2015-03-31 | 136.29 | $91.86 | 1.48 |
| 2014-12-31 | 110.44 | $90.45 | 1.22 |
| 2014-09-30 | 104.77 | $89.81 | 1.17 |
| 2014-06-30 | 93.91 | $88.81 | 1.06 |
| 2014-03-31 | 86.52 | $86.36 | 1.00 |
| 2013-12-31 | 79.91 | $84.44 | 0.95 |
| 2013-09-30 | 72.02 | $83.76 | 0.86 |
| 2013-06-30 | 70.19 | $81.95 | 0.86 |
| 2013-03-31 | 56.52 | $80.87 | 0.70 |
| 2012-12-31 | 51.68 | $78.11 | 0.66 |
| 2012-09-30 | 48.96 | $75.85 | 0.65 |
| 2012-06-30 | 53.58 | $72.71 | 0.74 |
| 2012-03-31 | 61.73 | $70.91 | 0.87 |
| 2011-12-31 | 55.16 | $68.62 | 0.80 |
| 2011-09-30 | 54.16 | $67.92 | 0.80 |
| 2011-06-30 | 65.10 | $66.76 | 0.98 |
| 2011-03-31 | 57.48 | $65.04 | 0.88 |
| 2010-12-31 | 46.66 | $63.04 | 0.74 |
| 2010-09-30 | 46.48 | $61.71 | 0.75 |
| 2010-06-30 | 40.16 | $59.00 | 0.68 |
| 2010-03-31 | 52.83 | $56.84 | 0.93 |
| 2009-12-31 | 47.84 | $55.28 | 0.87 |
| 2009-09-30 | 38.87 | $49.17 | 0.79 |
| 2009-06-30 | 41.76 | $46.63 | 0.90 |
| 2009-03-31 | 31.16 | $44.22 | 0.70 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Services | $93.604B | $171.340B |
| Elevance Health Inc. operates as a health benefits company. It supports consumers, families and communities across the entire care journey connecting to the care, support and resources to lead healthier lives. Elevance Health Inc., formerly known as Anthem Inc., is based in Indianapolis, Indiana. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Cencora (COR) | United States | $48.412B | 17.85 |
| DiDi Global (DIDIY) | China | $22.941B | 0.00 |
| Natera (NTRA) | United States | $22.359B | 0.00 |
| ICON (ICLR) | Ireland | $17.552B | 15.63 |
| Viatris (VTRS) | United States | $15.815B | 4.87 |
| Avantor (AVTR) | United States | $13.857B | 20.78 |
| Revvity (RVTY) | United States | $13.522B | 23.49 |
| CochLear (CHEOY) | Australia | $12.586B | 0.00 |
| BioMerieux (BMXMF) | France | $12.119B | 0.00 |
| Solventum (SOLV) | United States | $12.029B | 0.00 |
| Medpace Holdings (MEDP) | United States | $10.624B | 29.93 |
| Charles River Laboratories (CRL) | United States | $9.930B | 19.19 |
| HealthEquity (HQY) | United States | $9.139B | 49.60 |
| Doximity (DOCS) | United States | $8.961B | 52.75 |
| Sonic Healthcare (SKHHY) | Australia | $8.813B | 0.00 |
| Bausch + Lomb (BLCO) | Canada | $6.977B | 32.47 |
| Life Times (LTH) | United States | $5.046B | 33.40 |
| Organon (OGN) | United States | $3.835B | 3.87 |
| Sotera Health (SHC) | United States | $3.515B | 18.80 |
| BrightSpring Health Services (BTSG) | United States | $3.265B | 69.44 |
| Surgery Partners (SGRY) | United States | $2.968B | 33.84 |
| Concentras Parent (CON) | United States | $2.735B | 0.00 |
| PACS (PACS) | United States | $2.522B | 0.00 |
| Alignment Healthcare (ALHC) | United States | $2.320B | 0.00 |
| Ardent Health Partners (ARDT) | United States | $2.255B | 0.00 |
| Premier (PINC) | United States | $2.155B | 11.21 |
| Ryman Healthcare (RYHTY) | New Zealand | $1.995B | 0.00 |
| GeneDx Holdings (WGS) | United States | $1.980B | 0.00 |
| Teladoc Health (TDOC) | United States | $1.791B | 0.00 |
| GoodRx Holdings (GDRX) | United States | $1.635B | 42.90 |
| Progyny (PGNY) | United States | $1.275B | 25.81 |
| Pediatrix Medical (MD) | United States | $1.267B | 12.40 |
| CareDx (CDNA) | United States | $1.211B | 0.00 |
| Establishment Labs Holdings (ESTA) | $1.193B | 0.00 | |
| AMN Healthcare Services Inc (AMN) | United States | $0.978B | 6.62 |
| Embecta (EMBC) | United States | $0.808B | 5.38 |
| QDM (QDMI) | Hong Kong, SAR China | $0.790B | 20.69 |
| Agilon Health (AGL) | United States | $0.733B | 0.00 |
| SBC Medicals (SBC) | United States | $0.670B | 0.00 |
| InnovAge Holding (INNV) | United States | $0.627B | 0.00 |
| Auna S.A (AUNA) | Luxembourg | $0.526B | 0.00 |
| Sonida Senior Living (SNDA) | United States | $0.467B | 0.00 |
| DocGo (DCGO) | United States | $0.420B | 15.85 |
| Enhabit (EHAB) | United States | $0.376B | 32.48 |
| COMPASS Pathways (CMPS) | United Kingdom | $0.304B | 0.00 |
| ModivCare (MODV) | United States | $0.250B | 13.54 |
| LifeMD (LFMD) | United States | $0.246B | 0.00 |
| Sera Prognostics (SERA) | United States | $0.206B | 0.00 |
| Biodesix (BDSX) | United States | $0.175B | 0.00 |
| Nutex Health (NUTX) | United States | $0.173B | 0.00 |
| Beauty Health (SKIN) | United States | $0.173B | 0.00 |
| MultiPlan (MPLN) | United States | $0.114B | 0.00 |
| Ascend Wellness Holdings (AAWH) | United States | $0.094B | 0.00 |
| So-Young (SY) | China | $0.093B | 17.98 |
| Singular Genomics Systems (OMIC) | United States | $0.055B | 0.00 |
| OncoCyte (OCX) | United States | $0.045B | 0.00 |
| NeueHealth (NEUE) | United States | $0.042B | 1.11 |
| Co-Diagnostics (CODX) | United States | $0.034B | 0.00 |
| Pheton Holdings (PTHL) | China | $0.031B | 0.00 |
| IceCure Medical (ICCM) | Israel | $0.027B | 0.00 |
| NeuroOne Medical Technologies (NMTC) | United States | $0.022B | 0.00 |
| Oncology Institute (TOI) | United States | $0.012B | 0.00 |
| SeaStar Medical Holding (ICU) | United States | $0.010B | 0.00 |
| XWELL (XWEL) | United States | $0.008B | 0.00 |
| Intelligent Bio Solutions (INBS) | United States | $0.007B | 0.00 |
| KindlyMD (KDLY) | United States | $0.006B | 0.00 |
| BioNexus Gene Lab (BGLC) | $0.005B | 0.00 | |
| ISpecimen (ISPC) | United States | $0.004B | 0.00 |
| NewGenIvf Group (NIVF) | Thailand | $0.002B | 0.00 |
| Aclarion (ACON) | United States | $0.002B | 0.00 |
| Cano Health (CANOQ) | United States | $0.001B | 0.00 |